Comparison of Online Adaptive and Non-adaptive Magnetic Resonance Image-guided Radiation Therapy in Prostate Cancer Using Dose Accumulation

Overview

Journal Phys Imaging Radiat Oncol

Specialty Oncology

Date 2024 Nov 18

PMID 39554802

Authors

Martina Murr

Daniel Wegener

Simon Boke

Cihan Gani

David Monnich

Maximilian Niyazi

Moritz Schneider

Daniel Zips

Arndt-Christian Muller

Daniela Thorwarth

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: Conventional image-guided radiotherapy (conv-IGRT) is standard in prostate cancer (PC) but does not account for inter-fraction anatomical changes. Online-adaptive magnetic resonance-guided RT (OA-MRgRT) may improve organ-at-risk (OARs) sparing and clinical target volume (CTV) coverage. The aim of this study was to analyze accumulated OAR and target doses in PC after OA-MRgRT and conv-IGRT in comparison to pre-treatment reference planning (refPlan).

Material And Methods: Ten patients with PC, previously treated with OA-MRgRT at the 1.5 T MR-Linac (20x3Gy), were included. Accumulated OA-MRgRT doses were determined by deformably registering all fraction's MR-images. Conv-IGRT was simulated through rigid registration of the planning computed tomography with each fraction's MR-image for dose mapping/accumulation. Dose-volume parameters (DVPs), including CTV D50% and D98%, rectum, bladder, urethra, Dmax and V56Gy for OA-MRgRT, conv-IGRT and refPlan were compared using the Wilcoxon signed-rank test. Clinical relevance of accumulated dose differences was analyzed using a normal-tissue complication-probability model.

Results: CTV-DVPs were comparable, whereas OA-MRgRT yielded decreased median OAR-DVPs compared to conv-IGRT, except for bladder V56Gy. OA-MRgRT demonstrated significantly lower median rectum Dmax over conv-IGRT (59.1/59.9 Gy, p = 0.006) and refPlan (60.1 Gy, p = 0.012). Similarly, OA-MRgRT yielded reduced median bladder Dmax compared to conv-IGRT (60.0/60.4 Gy, p = 0.006), and refPlan (61.2 Gy, p = 0.002). Overall, accumulated dose differences were small and did not translate into clinically relevant effects.

Conclusion: Deformably accumulated OA-MRgRT using 20x3Gy in PC showed significant but small dosimetric differences comparted to conv-IGRT. Feasibility of a dose accumulation methodology was demonstrated, which may be relevant for evaluating future hypo-fractionated OA-MRgRT approaches.

References

Palma G, Monti S, Cella L . Voxel-based analysis in radiation oncology: A methodological cookbook. Phys Med. 2020; 69:192-204. DOI: 10.1016/j.ejmp.2019.12.013. View

Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider J . Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991; 21(1):109-22. DOI: 10.1016/0360-3016(91)90171-y. View

Nenoff L, Amstutz F, Murr M, Archibald-Heeren B, Fusella M, Hussein M . Review and recommendations on deformable image registration uncertainties for radiotherapy applications. Phys Med Biol. 2023; 68(24). PMC: 10725576. DOI: 10.1088/1361-6560/ad0d8a. View

Hernandez V, Hansen C, Widesott L, Back A, Canters R, Fusella M . What is plan quality in radiotherapy? The importance of evaluating dose metrics, complexity, and robustness of treatment plans. Radiother Oncol. 2020; 153:26-33. DOI: 10.1016/j.radonc.2020.09.038. View

Kunzel L, Leibfarth S, Dohm O, Muller A, Zips D, Thorwarth D . Automatic VMAT planning for post-operative prostate cancer cases using particle swarm optimization: A proof of concept study. Phys Med. 2019; 69:101-109. DOI: 10.1016/j.ejmp.2019.12.007. View

Murr M, Bernchou U, Bubula-Rehm E, Ruschin M, Sadeghi P, Voet P . A multi-institutional comparison of retrospective deformable dose accumulation for online adaptive magnetic resonance-guided radiotherapy. Phys Imaging Radiat Oncol. 2024; 30:100588. PMC: 11176923. DOI: 10.1016/j.phro.2024.100588. View

Murr M, Brock K, Fusella M, Hardcastle N, Hussein M, Jameson M . Applicability and usage of dose mapping/accumulation in radiotherapy. Radiother Oncol. 2023; 182:109527. PMC: 11877414. DOI: 10.1016/j.radonc.2023.109527. View

Wahlstedt I, Smith A, Andersen C, Behrens C, Bekke S, Boye K . Interfractional dose accumulation for MR-guided liver SBRT: Variation among algorithms is highly patient- and fraction-dependent. Radiother Oncol. 2022; 182:109448. DOI: 10.1016/j.radonc.2022.109448. View

Brand D, Bruningk S, Wilkins A, Naismith O, Gao A, Syndikus I . The Fraction Size Sensitivity of Late Genitourinary Toxicity: Analysis of Alpha/Beta (α/β) Ratios in the CHHiP Trial. Int J Radiat Oncol Biol Phys. 2022; 115(2):327-336. DOI: 10.1016/j.ijrobp.2022.08.030. View

10.

Kawula M, Hadi I, Nierer L, Vagni M, Cusumano D, Boldrini L . Patient-specific transfer learning for auto-segmentation in adaptive 0.35 T MRgRT of prostate cancer: a bi-centric evaluation. Med Phys. 2022; 50(3):1573-1585. DOI: 10.1002/mp.16056. View

11.

Ghanem A, Elsaid A, Elshaikh M, Khedr G . Volumetric-Modulated Arc Radiotherapy with Daily Image-Guidance Carries Better Toxicity Profile for Higher Risk Prostate Cancer. Asian Pac J Cancer Prev. 2021; 22(1):61-68. PMC: 8184174. DOI: 10.31557/APJCP.2021.22.1.61. View

12.

Sonke J, Aznar M, Rasch C . Adaptive Radiotherapy for Anatomical Changes. Semin Radiat Oncol. 2019; 29(3):245-257. DOI: 10.1016/j.semradonc.2019.02.007. View

13.

Xiong Y, Rabe M, Rippke C, Kawula M, Nierer L, Kluter S . Impact of daily plan adaptation on accumulated doses in ultra-hypofractionated magnetic resonance-guided radiation therapy of prostate cancer. Phys Imaging Radiat Oncol. 2024; 29:100562. PMC: 10924058. DOI: 10.1016/j.phro.2024.100562. View

14.

Jiang J, Choi C, Deasy J, Rimner A, Thor M, Veeraraghavan H . Artificial intelligence-based automated segmentation and radiotherapy dose mapping for thoracic normal tissues. Phys Imaging Radiat Oncol. 2024; 29:100542. PMC: 10869275. DOI: 10.1016/j.phro.2024.100542. View

15.

Burman C, Kutcher G, Emami B, Goitein M . Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys. 1991; 21(1):123-35. DOI: 10.1016/0360-3016(91)90172-z. View

16.

Johannesson V, Gunnlaugsson A, Nilsson P, Brynolfsson P, Kjellen E, Wieslander E . Dose-volume relationships of planned versus estimated delivered radiation doses to pelvic organs at risk and side effects in patients treated with salvage radiotherapy for recurrent prostate cancer. Tech Innov Patient Support Radiat Oncol. 2024; 29:100231. PMC: 10772375. DOI: 10.1016/j.tipsro.2023.100231. View

17.

LYMAN J . Complication probability as assessed from dose-volume histograms. Radiat Res Suppl. 1985; 8:S13-9. View

18.

Muurholm C, Ravkilde T, Skouboe S, Worm E, Hansen R, Hoyer M . Real-time dose-guidance in radiotherapy: Proof of principle. Radiother Oncol. 2021; 164:175-182. DOI: 10.1016/j.radonc.2021.09.024. View

19.

Christiansen R, Dysager L, Hansen C, Jensen H, Schytte T, Nyborg C . Online adaptive radiotherapy potentially reduces toxicity for high-risk prostate cancer treatment. Radiother Oncol. 2021; 167:165-171. DOI: 10.1016/j.radonc.2021.12.013. View

20.

Chetty I, Rosu-Bubulac M . Deformable Registration for Dose Accumulation. Semin Radiat Oncol. 2019; 29(3):198-208. DOI: 10.1016/j.semradonc.2019.02.002. View